[{"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-001", "question": "A 27-year-old G1P0 at 9 weeks' gestation presents with intractable nausea and vomiting, 7-kg weight loss, new-onset jaundice, and confusion over 3 days. She has no prior liver disease or alcohol use. Vitals: T 37.2°C, HR 122, BP 100/62, RR 18, SpO2 98% RA. Exam: scleral icterus, moderate right upper quadrant tenderness without rebound, asterixis. Labs: Na 132, K 3.1, bicarbonate 19, creatinine 1.2 mg/dL (baseline 0.6), AST 545 U/L, ALT 510 U/L, ALP 225 U/L, total bilirubin 12.4 mg/dL (direct 8.1), INR 2.6, ammonia 102 µmol/L, β-hCG markedly elevated for gestational age, thyroid studies: TSH low, free T4 and T3 mildly elevated. Abdominal ultrasound: single live intrauterine pregnancy, normal hepatic and portal vasculature, no biliary dilation, mild fatty liver change. Viral hepatitis serologies and autoimmune markers are pending. She is receiving IV fluids and antiemetics but continues to deteriorate neurologically. Which of the following is the most appropriate immediate next management step?", "options": ["Administer high-dose IV methylprednisolone and defer pregnancy decisions until serologies return", "Urgently proceed with uterine evacuation and initiate N-acetylcysteine infusion", "Start high-dose IV thiamine and parenteral nutrition while continuing pregnancy", "List for emergent liver transplantation without altering pregnancy status", "Administer propylthiouracil and beta-blockers to treat probable gestational thyrotoxicosis and reassess"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with hyperemesis gravidarum-associated acute liver failure with encephalopathy and coagulopathy; maternal survival takes precedence, and rapid uterine evacuation plus N-acetylcysteine offers the best chance to reverse fulminant hepatic injury. Steroids (A) address autoimmune hepatitis, which is unconfirmed and too slow. Thiamine and nutrition (C) are supportive but insufficient in fulminant failure with encephalopathy. Immediate transplantation listing (D) may be needed but should follow rapid removal of the precipitating factor. Treating mild gestational thyrotoxicosis alone (E) will not address the primary life-threatening hepatic process.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with Acute Liver Failure (ALF), evidenced by coagulopathy (INR 2.6) and encephalopathy (confusion, asterixis). The constellation of intractable vomiting, markedly elevated beta-hCG, and gestational thyrotoxicosis (suppressed TSH, elevated free T4/T3) strongly implicates the pregnancy itself (specifically the high hormonal burden) as the driver of the hepatic decompensation. While typical Hyperemesis Gravidarum (HG) rarely causes fulminant failure, the stem constructs a scenario where the pregnancy is the precipitating cause of life-threatening maternal organ failure. In such extremis, maternal survival takes precedence, and removal of the precipitating factor (uterine evacuation) is the definitive management. N-acetylcysteine is the standard of care for non-acetaminophen ALF to improve transplant-free survival. Option A (steroids) treats autoimmune hepatitis, which is unconfirmed and less likely given the hCG-specific clues. Option C (thiamine) treats Wernicke's but does not address the liver failure. Option D (transplant) is premature without addressing the underlying cause. Option E treats the secondary thyroid phenomenon. Therefore, B is the only defensible best answer within the exam's logic.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with Acute Liver Failure (ALF), evidenced by coagulopathy (INR 2.6) and encephalopathy (confusion, asterixis). The constellation of intractable vomiting, markedly elevated beta-hCG, and gestational thyrotoxicosis (suppressed TSH, elevated free T4/T3) strongly implicates the pregnancy itself (specifically the high hormonal burden) as the driver of the hepatic decompensation. While typical Hyperemesis Gravidarum (HG) rarely causes fulminant failure, the stem constructs a scenario where the pregnancy is the precipitating cause of life-threatening maternal organ failure. In such extremis, maternal survival takes precedence, and removal of the precipitating factor (uterine evacuation) is the definitive management. N-acetylcysteine is the standard of care for non-acetaminophen ALF to improve transplant-free survival. Option A (steroids) treats autoimmune hepatitis, which is unconfirmed and less likely given the hCG-specific clues. Option C (thiamine) treats Wernicke's but does not address the liver failure. Option D (transplant) is premature without addressing the underlying cause. Option E treats the secondary thyroid phenomenon. Therefore, B is the only defensible best answer within the exam's logic.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-002", "question": "A 63-year-old man with long-standing hypertension and ischemic cardiomyopathy (EF 30%) presents with acute right hemiplegia and aphasia 45 minutes after symptom onset. NIHSS is 18. Noncontrast CT head shows no hemorrhage. CT angiography shows left M1 occlusion with favorable collaterals; CT perfusion suggests a large salvageable penumbra. ECG shows sinus rhythm with frequent PVCs. High-sensitivity troponin is mildly elevated and flat on serial testing. You plan IV thrombolysis and urgent mechanical thrombectomy. Which of the following additional acute management steps is most appropriate?", "options": ["Initiate IV unfractionated heparin infusion before mechanical thrombectomy due to high cardioembolic risk", "Administer IV labetalol to reduce blood pressure to <140/90 mm Hg prior to thrombolysis", "Start high-dose statin and delay any antiplatelet therapy until 24 hours after thrombolysis", "Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis", "Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "The correct step is to start high-intensity statin immediately and delay antiplatelets until 24 hours after thrombolysis and repeat imaging, per acute ischemic stroke guidelines. Heparin before thrombectomy (A) increases hemorrhagic risk with no proven benefit. Lowering BP below 140/90 (B) before tPA is too aggressive and can worsen cerebral perfusion; only treat if >185/110 to that threshold. Dual antiplatelets immediately after tPA (D) markedly increases hemorrhage risk. Intra-aortic balloon pump (E) has no role in this setting and carries procedural risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic acute ischemic stroke scenario involving a patient eligible for both IV thrombolysis (IVT) and mechanical thrombectomy. The item tests knowledge of peri-thrombolytic management guidelines (AHA/ASA). Option C is the correct best answer: guidelines strictly mandate delaying antiplatelet and anticoagulant therapy for 24 hours after IVT (until follow-up imaging rules out transformation) to prevent hemorrhage, while initiating high-intensity statin is appropriate for secondary prevention. The distractors are clearly incorrect based on standard safety parameters: Option A (heparin) and Option D (DAPT) are contraindicated immediately post-IVT due to bleeding risk. Option B suggests an incorrect blood pressure target (<140/90 mm Hg); the threshold for IVT is <185/110 mm Hg, and aggressive lowering below this can cause penumbral hypoperfusion. Option E is not indicated absent cardiogenic shock. The item is logically valid, medically accurate, and relies on widely accepted guidelines.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic acute ischemic stroke scenario involving a patient eligible for both IV thrombolysis (IVT) and mechanical thrombectomy. The item tests knowledge of peri-thrombolytic management guidelines (AHA/ASA). Option C is the correct best answer: guidelines strictly mandate delaying antiplatelet and anticoagulant therapy for 24 hours after IVT (until follow-up imaging rules out transformation) to prevent hemorrhage, while initiating high-intensity statin is appropriate for secondary prevention. The distractors are clearly incorrect based on standard safety parameters: Option A (heparin) and Option D (DAPT) are contraindicated immediately post-IVT due to bleeding risk. Option B suggests an incorrect blood pressure target (<140/90 mm Hg); the threshold for IVT is <185/110 mm Hg, and aggressive lowering below this can cause penumbral hypoperfusion. Option E is not indicated absent cardiogenic shock. The item is logically valid, medically accurate, and relies on widely accepted guidelines.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-003", "question": "A 34-year-old woman with SLE (malar rash, arthritis, class III lupus nephritis on biopsy) on mycophenolate and low-dose prednisone presents with 3 months of progressive exertional dyspnea and dry cough. She has no smoking history. Vitals: HR 96, BP 112/70, RR 18, SpO2 94% RA. Exam: fine bibasilar crackles, no peripheral edema. Labs: creatinine 1.0 mg/dL, ANA 1:640 homogeneous, anti-dsDNA mildly elevated, complements low, ESR 18 mm/hr, CRP 2 mg/L. PFTs: FVC 65% predicted, FEV1/FVC 0.82, DLCO 40% predicted. HRCT: diffuse ground-glass opacities with scattered areas of consolidation and traction bronchiectasis, predominantly in lower lobes, no honeycombing. BAL: lymphocytic predominance, cultures negative. Echocardiogram: normal LV function, PASP 30 mm Hg. Which of the following is the most appropriate next step in management?", "options": ["Escalate mycophenolate dose and add high-dose oral prednisone without further diagnostics", "Switch mycophenolate to cyclophosphamide and simultaneously list for lung transplantation", "Perform surgical lung biopsy to distinguish organizing pneumonia from NSIP", "Add rituximab while continuing mycophenolate at the same dose", "Initiate nintedanib in addition to current immunosuppression for progressive fibrosing ILD"], "answer": "E", "answer_index": 4, "explanation": "This is SLE-associated progressive fibrosing interstitial lung disease with traction bronchiectasis and physiologic restriction despite immunosuppression; nintedanib has evidence for slowing decline in progressive fibrosing ILDs, including CTD-ILD. Blind escalation of steroids/mycophenolate (A) risks toxicity without clear additional benefit. Routine upfront lung transplant listing (B) is premature. Lung biopsy (C) is high risk and unlikely to alter management given established CTD-ILD pattern. Rituximab (D) can be considered, but antifibrotic therapy specifically targets the progressive fibrosing phenotype and is strongly indicated here.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a patient with SLE-associated ILD progressing despite first-line immunosuppression (mycophenolate). The clinical picture shows a 'progressive fibrosing' phenotype (traction bronchiectasis, decline) which aligns with the specific indication for nintedanib (Option E), supported by the INBUILD trial data for non-IPF progressive fibrosing ILDs. \\n\\nHowever, the vignette also describes significant active inflammation (diffuse ground-glass opacities, consolidation, lymphocytic BAL, serologic activity). In clinical practice, intensifying immunosuppression (e.g., switching to cyclophosphamide or adding rituximab) is often the priority to reverse active inflammation before or alongside antifibrotic therapy. Option D (Rituximab) is a strong, medically defensible alternative. Nevertheless, Option E is the intended best answer because Option B is invalidated by the premature 'list for lung transplantation' clause, Option A suggests escalating a drug the patient is failing, and Option C is unnecessary/risky. Option E is the only choice that specifically addresses the 'progressive fibrosing' label emphasized in the stem, making it the unique best answer in the context of board-exam logic regarding new drug indications.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a patient with SLE-associated ILD progressing despite first-line immunosuppression (mycophenolate). The clinical picture shows a 'progressive fibrosing' phenotype (traction bronchiectasis, decline) which aligns with the specific indication for nintedanib (Option E), supported by the INBUILD trial data for non-IPF progressive fibrosing ILDs. \n\nHowever, the vignette also describes significant active inflammation (diffuse ground-glass opacities, consolidation, lymphocytic BAL, serologic activity). In clinical practice, intensifying immunosuppression (e.g., switching to cyclophosphamide or adding rituximab) is often the priority to reverse active inflammation before or alongside antifibrotic therapy. Option D (Rituximab) is a strong, medically defensible alternative. Nevertheless, Option E is the intended best answer because Option B is invalidated by the premature 'list for lung transplantation' clause, Option A suggests escalating a drug the patient is failing, and Option C is unnecessary/risky. Option E is the only choice that specifically addresses the 'progressive fibrosing' label emphasized in the stem, making it the unique best answer in the context of board-exam logic regarding new drug indications.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-004", "question": "A 51-year-old woman with poorly controlled type 2 diabetes and prior pelvic radiation for cervical cancer presents with 5 days of fever, worsening lower abdominal pain, and foul vaginal discharge. She is hypotensive and tachycardic. Exam: diffuse lower abdominal tenderness with guarding, necrotic friable tissue at the posterior vaginal fornix with gas bubbles and crepitus extending toward the rectovaginal septum. Labs: WBC 19,000/µL, lactate 4.5 mmol/L, creatinine 2.1 mg/dL. CT abdomen/pelvis with contrast: extensive gas in the pelvis tracking along fascial planes into the perineum, no discrete drainable collection, suspected uterine and vaginal wall necrosis. Blood cultures are drawn, and broad-spectrum IV antibiotics and aggressive fluids are started. Which is the most appropriate next step?", "options": ["Urgent total abdominal hysterectomy with wide radical debridement of necrotic pelvic and perineal tissue", "Percutaneous CT-guided drainage of gas-containing pelvic spaces plus continued maximal antibiotics", "Hyperbaric oxygen therapy as a temporizing measure before any surgical intervention", "Emergent exploratory laparotomy limited to diagnostic assessment and peritoneal lavage", "Conservative management with antibiotics and close ICU monitoring to avoid worsening radiation injury"], "answer": "A", "answer_index": 0, "explanation": "The clinical picture is necrotizing pelvic soft tissue infection (type I Fournier-like process) involving uterus and vagina in a radiated field, requiring immediate radical surgical debridement including hysterectomy. Percutaneous drainage (B) is inadequate for necrotizing fasciitis. Hyperbaric oxygen (C) may be adjunctive but never replaces urgent debridement. Exploratory laparotomy without aggressive debridement (D) fails to control source. Conservative management (E) carries an almost universally fatal risk in necrotizing infections.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient in septic shock with a necrotizing soft tissue infection (NSTI) of the pelvis and perineum, evidenced by crepitus, necrotic tissue, and gas tracking on CT. The specific mention of uterine necrosis and gas mandates immediate surgical source control. Option A is the only choice that addresses the pathology with the required standard of care: urgent radical debridement and removal of the necrotic organ (hysterectomy). Option B is inappropriate as there is no drainable collection and percutaneous drainage is insufficient for NSTI. Option C is an adjunctive therapy that cannot replace or delay surgical debridement. Option D is insufficient because it limits the intervention to diagnosis/lavage rather than the necessary debridement. Option E is dangerous, as conservative management of NSTI is almost universally fatal. The question is medically accurate, logically sound, and possesses a unique, defensible best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient in septic shock with a necrotizing soft tissue infection (NSTI) of the pelvis and perineum, evidenced by crepitus, necrotic tissue, and gas tracking on CT. The specific mention of uterine necrosis and gas mandates immediate surgical source control. Option A is the only choice that addresses the pathology with the required standard of care: urgent radical debridement and removal of the necrotic organ (hysterectomy). Option B is inappropriate as there is no drainable collection and percutaneous drainage is insufficient for NSTI. Option C is an adjunctive therapy that cannot replace or delay surgical debridement. Option D is insufficient because it limits the intervention to diagnosis/lavage rather than the necessary debridement. Option E is dangerous, as conservative management of NSTI is almost universally fatal. The question is medically accurate, logically sound, and possesses a unique, defensible best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-005", "question": "A 76-year-old man with permanent atrial fibrillation on apixaban, CKD stage 3b, and prior TIA undergoes TAVR for symptomatic severe aortic stenosis. Preprocedure echo: EF 55%, no intracardiac thrombus, moderate MAC, mild-moderate MR. Postprocedure, he develops acute severe dyspnea and hypotension 2 hours later. Echo: hyperdynamic LV with near-complete mid-cavity obliteration in systole, peak LVOT gradient 80 mm Hg, systolic anterior motion (SAM) of the mitral valve, severe MR, intact TAVR function. Which of the following is the most appropriate immediate management?", "options": ["Start high-dose IV furosemide and nitroprusside to rapidly reduce preload and afterload", "Administer aggressive IV crystalloids and start a phenylephrine infusion while reducing inotropes", "Urgently return to the cath lab for balloon post-dilatation of the TAVR prosthesis", "Begin IV milrinone infusion to augment contractility and improve forward flow", "Perform emergent surgical myectomy with mitral valve repair"], "answer": "B", "answer_index": 1, "explanation": "This is dynamic LVOT obstruction with SAM and severe MR precipitated by TAVR and low preload; management mirrors hypertrophic obstructive physiology-volume expansion and pure alpha-agonist (phenylephrine) to increase afterload while avoiding inotropes. Diuresis and vasodilators (A) and inotropes (D) worsen obstruction. Post-dilatation of the valve (C) is not indicated as prosthetic function is normal. Emergent surgery (E) is reserved for refractory cases after optimal medical hemodynamic management has failed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic case of dynamic Left Ventricular Outflow Tract (LVOT) obstruction (often called \\\"suicide LV\\\") following TAVR. The relief of fixed aortic stenosis unmasks septal hypertrophy, leading to Systolic Anterior Motion (SAM) of the mitral valve, severe MR, and hypotension, particularly if the patient is hypovolemic or hyperdynamic. The pathophysiology mirrors Hypertrophic Obstructive Cardiomyopathy (HOCM). Immediate management requires increasing preload (fluids), increasing afterload (phenylephrine), and reducing contractility (stopping inotropes or adding beta-blockers) to reduce the gradient. Option B correctly identifies the need for volume expansion and alpha-agonists. Options A (diuretics/vasodilators) and D (inotropes/vasodilators) would decrease LV filling or increase contractility, catastrophically worsening the obstruction. Option C is incorrect because the TAVR function is intact; the gradient is subvalvular. Option E is reserved for refractory cases, not immediate resuscitation. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic case of dynamic Left Ventricular Outflow Tract (LVOT) obstruction (often called \"suicide LV\") following TAVR. The relief of fixed aortic stenosis unmasks septal hypertrophy, leading to Systolic Anterior Motion (SAM) of the mitral valve, severe MR, and hypotension, particularly if the patient is hypovolemic or hyperdynamic. The pathophysiology mirrors Hypertrophic Obstructive Cardiomyopathy (HOCM). Immediate management requires increasing preload (fluids), increasing afterload (phenylephrine), and reducing contractility (stopping inotropes or adding beta-blockers) to reduce the gradient. Option B correctly identifies the need for volume expansion and alpha-agonists. Options A (diuretics/vasodilators) and D (inotropes/vasodilators) would decrease LV filling or increase contractility, catastrophically worsening the obstruction. Option C is incorrect because the TAVR function is intact; the gradient is subvalvular. Option E is reserved for refractory cases, not immediate resuscitation. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-006", "question": "A 42-year-old man who injects drugs presents with 10 days of fever, severe back pain, and new right leg weakness. Vitals: T 38.8°C, HR 108, BP 122/74. Exam: midline lumbar tenderness, right leg 3/5 strength with hyperreflexia, left leg 5/5, intact sensation, no bowel/bladder symptoms. Labs: WBC 15,000/µL, ESR 96 mm/hr, CRP 120 mg/L. Blood cultures: MRSA in 2/2 sets. MRI lumbar spine with contrast: dorsal epidural collection L2-L4 with significant canal compromise and enhancement consistent with epidural abscess, plus adjacent vertebral osteomyelitis; no discrete psoas abscess. He is started on IV vancomycin. Neurosurgery feels surgery is high risk due to severe cardiomyopathy (EF 20%) and active drug use, recommending medical therapy unless deterioration. What is the most appropriate next step?", "options": ["Continue IV vancomycin alone with close neurologic monitoring for at least 6 weeks", "Add rifampin to vancomycin to enhance penetration into epidural space and bone", "Perform urgent surgical decompression and drainage despite high perioperative risk", "Switch to daptomycin plus ceftaroline to provide broader MRSA coverage", "Place percutaneous CT-guided drain into the epidural collection to avoid open surgery"], "answer": "C", "answer_index": 2, "explanation": "He has spinal epidural abscess with evolving motor deficit and significant canal compromise; urgent surgical decompression and drainage is indicated despite elevated operative risk, as delay risks permanent paralysis. Medical therapy alone (A, B, D) is inadequate once neurologic deficits are present. Percutaneous drainage (E) is not appropriate for epidural abscess causing cord compression, as it rarely achieves effective decompression or safe access to the epidural space.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item tests the management of spinal epidural abscess (SEA) with a neurological deficit. The presence of a new motor deficit (3/5 strength) is a strong indication for urgent surgical decompression (Option C) to prevent permanent paralysis, despite the high perioperative risk (EF 20%). Medical management (Option A) is typically reserved for neurologically intact patients or those with prohibitive risk where paralysis is accepted as a trade-off; here, the deficit is the priority. However, the item contains a significant medical inaccuracy: the MRI shows a collection at L2–L4 (cauda equina level), but the physical exam describes hyperreflexia (an upper motor neuron sign). Compression at L2–L4 should cause lower motor neuron signs (hyporeflexia/flaccidity). While this anatomical contradiction is confusing, it does not alter the management (decompression is indicated for both cord and cauda equina compression with deficit). The inclusion of the neurosurgeon's recommendation against surgery acts as a distractor, requiring the examinee to identify the correct standard of care over the consultant's opinion. The item is logically valid as a unique best answer exists despite the anatomical flaw.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item tests the management of spinal epidural abscess (SEA) with a neurological deficit. The presence of a new motor deficit (3/5 strength) is a strong indication for urgent surgical decompression (Option C) to prevent permanent paralysis, despite the high perioperative risk (EF 20%). Medical management (Option A) is typically reserved for neurologically intact patients or those with prohibitive risk where paralysis is accepted as a trade-off; here, the deficit is the priority. However, the item contains a significant medical inaccuracy: the MRI shows a collection at L2–L4 (cauda equina level), but the physical exam describes hyperreflexia (an upper motor neuron sign). Compression at L2–L4 should cause lower motor neuron signs (hyporeflexia/flaccidity). While this anatomical contradiction is confusing, it does not alter the management (decompression is indicated for both cord and cauda equina compression with deficit). The inclusion of the neurosurgeon's recommendation against surgery acts as a distractor, requiring the examinee to identify the correct standard of care over the consultant's opinion. The item is logically valid as a unique best answer exists despite the anatomical flaw.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-007", "question": "A 31-year-old woman presents with severe headaches, transient visual obscurations, and pulsatile tinnitus 6 months postpartum. She has gained 20 kg during and after pregnancy. BMI is 38 kg/m². Exam: bilateral papilledema, full strength, no focal deficits. MRI brain with and without contrast is normal. MRV shows smooth tapering and non-visualization of the terminal right transverse sinus with small caliber sigmoid sinus and jugular bulb; the left transverse sinus is dominant and widely patent. Lumbar puncture: opening pressure 34 cm H₂O, normal CSF studies. She is started on acetazolamide and advised weight loss but continues to have progressive visual field loss on serial perimetry over 8 weeks. What is the most appropriate next step in management?", "options": ["Place a ventriculoperitoneal shunt to lower intracranial pressure", "Perform right transverse sinus stenting across the narrowed segment", "Initiate high-dose oral topiramate instead of acetazolamide", "Perform optic nerve sheath fenestration to protect vision", "Start therapeutic anticoagulation for presumed chronic venous sinus thrombosis"], "answer": "D", "answer_index": 3, "explanation": "The patient has idiopathic intracranial hypertension with rapidly progressive visual loss despite maximal medical therapy; optic nerve sheath fenestration is the preferred intervention to promptly protect vision. VP shunting (A) is an option but has higher long-term failure and complication rates and is usually considered after or when ONSF is not feasible. Transverse sinus stenting (B) is usually reserved for documented significant pressure gradients and bilateral or dominant-sided stenosis; here the right sinus is small and nondominant. Topiramate (C) is an adjunct but insufficient alone given progressive visual decline. Anticoagulation (E) is not indicated without imaging evidence of thrombosis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a classic case of Idiopathic Intracranial Hypertension (IIH) refractory to medical management (acetazolamide, weight loss) with progressive visual field loss. This is a vision-threatening emergency requiring surgical intervention. The key (D, Optic Nerve Sheath Fenestration - ONSF) is the traditional board-preferred answer for cases where visual loss is the primary indication for surgery, as it directly decompresses the optic nerve. Option A (VP Shunt) is also a valid treatment for IIH but is often reserved for cases where headache is the prominent symptom or ONSF fails, due to higher long-term revision/complication rates. Option B (Stenting) is correctly ruled out by the MRV findings: stenting is indicated for significant stenosis with a pressure gradient, typically in the dominant sinus; here, the dominant left sinus is 'widely patent,' making stenting hemodynamically useless. Options C and E are medically inappropriate for fulminant visual loss or lack of thrombotic evidence. The item is logically sound, medically accurate, and discriminates well based on specific anatomical and clinical details.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a classic case of Idiopathic Intracranial Hypertension (IIH) refractory to medical management (acetazolamide, weight loss) with progressive visual field loss. This is a vision-threatening emergency requiring surgical intervention. The key (D, Optic Nerve Sheath Fenestration - ONSF) is the traditional board-preferred answer for cases where visual loss is the primary indication for surgery, as it directly decompresses the optic nerve. Option A (VP Shunt) is also a valid treatment for IIH but is often reserved for cases where headache is the prominent symptom or ONSF fails, due to higher long-term revision/complication rates. Option B (Stenting) is correctly ruled out by the MRV findings: stenting is indicated for significant stenosis with a pressure gradient, typically in the dominant sinus; here, the dominant left sinus is 'widely patent,' making stenting hemodynamically useless. Options C and E are medically inappropriate for fulminant visual loss or lack of thrombotic evidence. The item is logically sound, medically accurate, and discriminates well based on specific anatomical and clinical details.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-008", "question": "A 29-year-old woman with a history of two early first-trimester miscarriages and one unexplained fetal demise at 28 weeks presents for preconception counseling. She has livedo reticularis and episodes of digital ischemia in cold weather. Labs: platelets 110,000/µL, hemoglobin 11.5 g/dL, creatinine 0.9 mg/dL. Coagulation profile is normal. aPTT is mildly prolonged. Lupus anticoagulant is repeatedly positive; anticardiolipin IgG and anti-β2-glycoprotein I IgG are high-titer on two occasions 12 weeks apart. She has no personal history of venous or arterial thrombosis. Which of the following is the most appropriate pregnancy management plan?", "options": ["Low-dose aspirin alone starting preconception, escalate to prophylactic LMWH only if thrombosis occurs", "Therapeutic-dose LMWH plus low-dose aspirin starting at positive pregnancy test and continuing 6 weeks postpartum", "Prophylactic-dose LMWH plus low-dose aspirin starting at conception and stopping at delivery", "Low-dose aspirin only during pregnancy, with postpartum prophylactic LMWH for 6 weeks", "No anticoagulation unless she develops hypertensive disorders of pregnancy"], "answer": "B", "answer_index": 1, "explanation": "She meets criteria for high-risk obstetric antiphospholipid syndrome with recurrent pregnancy loss and triple-positive aPL; therapeutic-dose LMWH plus low-dose aspirin throughout pregnancy and 6 weeks postpartum provides optimal maternal and fetal protection. Aspirin alone (A, D, E) is inadequate in high-risk APS. Prophylactic-dose LMWH (C) may be used in lower-risk obstetric APS but is insufficient here given triple positivity and prior late fetal loss and thrombocytopenia suggestive of high thrombotic risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient has obstetric antiphospholipid syndrome (APS) defined by recurrent losses, a fetal demise >10 weeks, and triple-positive labs, with no history of thrombosis. Current major guidelines (ACOG, EULAR, CHEST) recommend prophylactic or intermediate-dose LMWH plus low-dose aspirin (LDA) during pregnancy and for 6 weeks postpartum. Option C correctly suggests prophylactic dose but incorrectly states to 'stop at delivery,' omitting critical postpartum prophylaxis when thrombotic risk is highest. Option B includes the correct duration (6 weeks postpartum) but specifies 'therapeutic-dose' LMWH. While therapeutic dosing is typically reserved for thrombotic APS (history of clots) or refractory cases, and prophylactic/intermediate is standard for obstetric APS, Option B is the only choice that provides coverage during both the antepartum and postpartum periods. Option C is unsafe due to the duration error. Therefore, B is the single best answer by elimination, despite the aggressive dosing which deviates from standard first-line guidance for non-thrombotic patients. The item is logically valid as a closed-set question.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient has obstetric antiphospholipid syndrome (APS) defined by recurrent losses, a fetal demise >10 weeks, and triple-positive labs, with no history of thrombosis. Current major guidelines (ACOG, EULAR, CHEST) recommend prophylactic or intermediate-dose LMWH plus low-dose aspirin (LDA) during pregnancy and for 6 weeks postpartum. Option C correctly suggests prophylactic dose but incorrectly states to 'stop at delivery,' omitting critical postpartum prophylaxis when thrombotic risk is highest. Option B includes the correct duration (6 weeks postpartum) but specifies 'therapeutic-dose' LMWH. While therapeutic dosing is typically reserved for thrombotic APS (history of clots) or refractory cases, and prophylactic/intermediate is standard for obstetric APS, Option B is the only choice that provides coverage during both the antepartum and postpartum periods. Option C is unsafe due to the duration error. Therefore, B is the single best answer by elimination, despite the aggressive dosing which deviates from standard first-line guidance for non-thrombotic patients. The item is logically valid as a closed-set question.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-009", "question": "A 55-year-old man from a region endemic for Lyme disease presents with 1 week of rapidly progressive bilateral leg weakness and numbness ascending from the feet, severe radicular pain, and new urinary retention. He was treated with oral doxycycline 3 weeks ago for erythema migrans following a hiking trip. Exam: symmetric lower extremity weakness 3/5 proximally and distally, hyperreflexia with bilateral Babinski signs, decreased pinprick below T10, preserved vibration sense in toes, and saddle hypesthesia. Cranial nerves are normal. MRI spine with contrast: multifocal enhancing lesions in the thoracic cord with associated leptomeningeal enhancement; no compressive lesion. CSF: WBC 220/µL (80% lymphocytes), protein 120 mg/dL, glucose 45 mg/dL (serum 90), oligoclonal bands present; CSF Lyme antibody index is elevated. HIV, syphilis, and TB tests are negative. What is the most appropriate treatment?", "options": ["High-dose IV methylprednisolone alone for presumed idiopathic transverse myelitis", "IV ceftriaxone 2 g daily for 4 weeks without steroids", "IV ceftriaxone 2 g daily plus high-dose IV methylprednisolone", "Oral doxycycline 100 mg BID for 28 days plus high-dose oral prednisone taper", "Plasma exchange for 5-7 sessions followed by IV ceftriaxone"], "answer": "B", "answer_index": 1, "explanation": "This is Lyme neuroborreliosis with meningomyelitis confirmed by elevated CSF Lyme antibody index and appropriate clinical picture; standard treatment is prolonged IV ceftriaxone without routine adjunctive steroids. Steroids alone (A) are inappropriate and may worsen infection. Adding high-dose steroids to antibiotics (C) has no proven benefit and may be harmful. Oral doxycycline (D) is inadequate for CNS parenchymal involvement. Plasma exchange (E) is used in severe autoimmune demyelination (e.g., NMO, ADEM) and is not indicated here once Lyme is confirmed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a classic case of Lyme neuroborreliosis manifesting as meningomyelitis (spastic paraparesis, sensory level, bladder dysfunction, lymphocytic pleocytosis, positive CSF Lyme index). The diagnosis is explicitly confirmed by the CSF Lyme antibody index. The clinical question focuses on management. Option B (IV ceftriaxone) is the correct standard-of-care treatment for Lyme myelitis (parenchymal CNS involvement) in the US, particularly given the severity and the fact that the patient recently received oral doxycycline (implying treatment failure or breakthrough). Option A (steroids alone) is contraindicated for active infection. Option C (antibiotics + steroids) is incorrect because routine adjunctive steroids are not indicated for Lyme neuroborreliosis and may be harmful; they are reserved for rare cases of severe cord swelling not described here as critical. Option D (oral doxycycline) is generally reserved for Lyme meningitis or cranial nerve palsy; IV therapy is preferred for myelitis, and the patient's history of recent doxycycline use makes retreatment with the same agent inappropriate. Option E is for autoimmune etiologies. The item is logically sound, medically accurate, and the distractors are well-defined.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a classic case of Lyme neuroborreliosis manifesting as meningomyelitis (spastic paraparesis, sensory level, bladder dysfunction, lymphocytic pleocytosis, positive CSF Lyme index). The diagnosis is explicitly confirmed by the CSF Lyme antibody index. The clinical question focuses on management. Option B (IV ceftriaxone) is the correct standard-of-care treatment for Lyme myelitis (parenchymal CNS involvement) in the US, particularly given the severity and the fact that the patient recently received oral doxycycline (implying treatment failure or breakthrough). Option A (steroids alone) is contraindicated for active infection. Option C (antibiotics + steroids) is incorrect because routine adjunctive steroids are not indicated for Lyme neuroborreliosis and may be harmful; they are reserved for rare cases of severe cord swelling not described here as critical. Option D (oral doxycycline) is generally reserved for Lyme meningitis or cranial nerve palsy; IV therapy is preferred for myelitis, and the patient's history of recent doxycycline use makes retreatment with the same agent inappropriate. Option E is for autoimmune etiologies. The item is logically sound, medically accurate, and the distractors are well-defined.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-010", "question": "A 48-year-old woman with seropositive rheumatoid arthritis (RF and anti-CCP positive) on methotrexate and adalimumab presents with subacute dyspnea and nonproductive cough. She has never smoked. Vitals: HR 104, BP 118/70, RR 22, SpO2 91% RA. Exam: fine bibasilar crackles, no wheezing, active small-joint synovitis. PFTs: FVC 58% predicted, FEV1/FVC 0.86, DLCO 35% predicted. HRCT: basilar-predominant reticulation, traction bronchiectasis, and patchy subpleural honeycombing consistent with usual interstitial pneumonia (UIP); no nodules or pleural effusions. Which of the following is the most appropriate disease-modifying management change?", "options": ["Continue methotrexate and adalimumab and add low-dose prednisone", "Discontinue methotrexate and switch adalimumab to rituximab", "Stop adalimumab and start tocilizumab while continuing methotrexate", "Continue current RA regimen and initiate mycophenolate mofetil for lung disease", "Add nintedanib while continuing methotrexate and adalimumab unchanged"], "answer": "B", "answer_index": 1, "explanation": "She has RA-associated ILD with a UIP pattern, in which methotrexate and TNF inhibitors are relatively contraindicated due to concerns for ILD progression; rituximab is preferred as an RA biologic in ILD. Continuing MTX/TNF with steroids (A) risks worsening lung fibrosis. Tocilizumab (C) has less data and does not address TNF-risk concerns. Adding mycophenolate (D) without removing potential pulmonary offenders is suboptimal. Nintedanib (E) may be beneficial in progressive fibrosing RA-ILD, but first-line is to remove MTX/TNF and choose an ILD-favorable biologic such as rituximab.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with seropositive Rheumatoid Arthritis (RA) presenting with new symptomatic Interstitial Lung Disease (ILD) with a UIP pattern and active synovitis. The management requires addressing both the articular disease and the pulmonary manifestations while minimizing potential drug toxicity. While the role of Methotrexate (MTX) in RA-ILD is debated (with recent evidence suggesting safety), standard board-exam heuristics and many guidelines recommend discontinuing MTX in the setting of new or worsening respiratory symptoms to rule out toxicity. Furthermore, TNF inhibitors (like Adalimumab) are relatively contraindicated in RA-ILD due to associations with worsening fibrosis or lack of efficacy in the lung. Rituximab is widely considered the preferred biologic for RA-ILD, particularly in seropositive patients, as it addresses both the arthritis and the lung disease. Therefore, Option B (stopping MTX and switching to Rituximab) is the most defensible best answer. Option E (Nintedanib) addresses fibrosis but fails to treat the active synovitis or remove the potentially harmful TNF inhibitor. Option A is incorrect because steroids alone do not address the maintenance regimen issues. Option C is less favorable as Rituximab has stronger evidence than Tocilizumab for RA-ILD.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with seropositive Rheumatoid Arthritis (RA) presenting with new symptomatic Interstitial Lung Disease (ILD) with a UIP pattern and active synovitis. The management requires addressing both the articular disease and the pulmonary manifestations while minimizing potential drug toxicity. While the role of Methotrexate (MTX) in RA-ILD is debated (with recent evidence suggesting safety), standard board-exam heuristics and many guidelines recommend discontinuing MTX in the setting of new or worsening respiratory symptoms to rule out toxicity. Furthermore, TNF inhibitors (like Adalimumab) are relatively contraindicated in RA-ILD due to associations with worsening fibrosis or lack of efficacy in the lung. Rituximab is widely considered the preferred biologic for RA-ILD, particularly in seropositive patients, as it addresses both the arthritis and the lung disease. Therefore, Option B (stopping MTX and switching to Rituximab) is the most defensible best answer. Option E (Nintedanib) addresses fibrosis but fails to treat the active synovitis or remove the potentially harmful TNF inhibitor. Option A is incorrect because steroids alone do not address the maintenance regimen issues. Option C is less favorable as Rituximab has stronger evidence than Tocilizumab for RA-ILD.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]